RT Journal Article
SR Electronic
T1 Integrating Buprenorphine Treatment for Opioid Use with Primary Care is Associated with Greater Retention in Treatment
JF The Journal of the American Board of Family
                Medicine
JO J Am Board Fam Med
FD American Board of Family Medicine
SP 206
OP 208
DO 10.3122/jabfm.2022.01.210292
VO 35
IS 1
A1 Anna G. Mirer
A1 Jeffrey D. Tiemstra
A1 Nicole E. Hammes
A1 Heather M. Cloum
A1 Karlee J. LaFavor
YR 2022
UL http://www.jabfm.org/content/35/1/206.abstract
AB Background: Medication-assisted treatment (MAT) for opioid use disorder (MAT) is encouraged for primary care use, but evidence for effectiveness when fully integrated with primary care versus provided separately is limited.Method: We conducted a retrospective cohort study of 257 MAT patients in our family medicine clinic to assess retention in treatment for patients receiving MAT integrated with primary care compared with our MAT patients who received their primary care elsewhere.Results: At 1 year after enrollment, 60% of patients receiving MAT integrated with primary care remained in treatment versus 43% of patients who received their primary care separately. In multivariate analysis, the patients receiving integrated MAT had a significantly lower risk of dropout (hazard ratio 0.49, 95% CI, 0.33-0.72).Conclusion: In this rural family medicine clinic, MAT integrated with primary care was associated with higher retention in treatment. Providing MAT as a component of comprehensive primary care may be superior to referring patients to an outside source.